Anti-arthritic effects of chlorogenic acid in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model

International Immunopharmacology

Volumn 11, Issue 1, 2011, Pages 23-28

  Chen, Wei Ping ^a   Tang, Jing Li ^a   Bao, Jia Peng ^a   Hu, Peng Fei ^a   Shi, Zhong Li ^a   Wu, Li Dong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

ACLT; Chlorogenic acid; Chondrocyte; Interleukin 1 ; Matrix metalloproteinase; Nuclear factor kappa B; Osteoarthritis

Indexed keywords

CHLOROGENIC ACID; COLLAGENASE 3; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; IN VIVO STUDY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL SURVIVAL; CELLS, CULTURED; CHLOROGENIC ACID; CHONDROCYTES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASES; NF-KAPPA B; OSTEOARTHRITIS; RABBITS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78651424917     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.09.021     Document Type: Article

References (38)

1. Y. Yoshihara, H. Nakamura, K. Obata, H. Yamada, T. Hayakawa, and K. Fujikawa Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis Ann Rheum Dis 59 2000 455 461
2. P.S. Burrage, K.S. Mix, and C.E. Brinckerhoff Matrix metalloproteinases: role in arthritis Front Biosci 11 2006 529 543
3. A.J. Fosang, K. Last, H. Stanton, D.B. Weeks, I.K. Campbell, and T.E. Hardingham Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants J Biol Chem 275 2000 33027 33037
4. B.C. Sondergaard, K. Henriksen, H. Wulf, S. Oestergaard, U. Schurigt, and R. Brauer Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation Osteoarthritis Cartilage 14 2006 738 748
5. J. Martel-Pelletier, D.J. Welsch, and J.P. Pelletier Metalloproteases and inhibitors in arthritic diseases Best Pract Res Clin Rheumatol 15 2001 805 829
6. R.M. Hembry, M.R. Bagga, J.T. Dingle, P.P. Thomas, and J.J. Reynolds Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo Virchows Arch 425 1994 413 424
7. C.I. Westacott, and M. Sharif Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25 1996 254 272
8. L. Dahlberg, R.C. Billinghurst, P. Manner, F. Nelson, G. Webb, and M. Ionescu Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1) Arthritis Rheum 43 2000 673 682
9. P.P. Tak, and G.S. Firestein NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 2001 7 11
10. M.S. Hayden, and S. Ghosh Signaling to NFκB Genes Dev 18 2004 2195 2224
11. J.I. Pulai, H. Chen, H.J. Im, S. Kumar, C. Hanning, and P.S. Hegde NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments J Immunol 174 2005 5781 5788
12. M. Lazzaroni, and G. Bianchi Porro Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations Aliment Pharmacol Ther Suppl 2 2004 48 58
13. R. van Koningsveld, P.I. Schmitz, F.G. Meche, L.H. Visser, J. Meulstee, and P.A. van Doorn Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial Lancet 363 2004 192 196
14. R. Feng, Y. Lu, L.L. Bowman, Y. Qian, V. Castranova, and M. Ding Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid J Biol Chem 280 2005 27888 27895
15. A. Farah, M. Monteiro, C.M. Donangelo, and S. Lafay Chlorogenic acids from green coffee extract are highly bioavailable in humans J Nutr 138 2008 2309 2315
16. Hoelzl C, Knasmuller S, Wagner KH, Elbling L, Huber W, Kager N, et al. Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Mol Nutr Food Res. doi:10.1002/mnfr. 201000048.
17. Pari L, Karthikesan K, Menon VP. Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Mol Cell Biochem. doi:10.1007/s11010-010-0442-5.
18. G. Bandyopadhyay, T. Biswas, K.C. Roy, S. Mandal, C. Mandal, and B.C. Pal Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells Blood 104 2004 2514 2522
19. Park HJ, Davis SR, Liang HY, Rosenberg DW, Bruno RS. Chlorogenic acid differentially alters hepatic and small intestinal thiol redox status without protecting against azoxymethane-induced colon carcinogenesis in mice. Nutr Cancer.62:362-70.
20. T. Krakauer The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines Immunopharmacol Immunotoxicol 24 2002 113 119
21. J. Shan, J. Fu, Z. Zhao, X. Kong, H. Huang, and L. Luo Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation Int Immunopharmacol 9 2009 1042 1048
22. M.D. dos Santos, M.C. Almeida, N.P. Lopes, and G.E. de Souza Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid Biol Pharm Bull 29 2006 2236 2240
23. U.H. Jin, J.Y. Lee, S.K. Kang, J.K. Kim, W.H. Park, and J.G. Kim A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus Life Sci 77 2005 2760 2769
24. H. Jo, H.J. Ahn, E.M. Kim, H.J. Kim, S.C. Seong, and I. Lee Effects of dehydroepiandrosterone on articular cartilage during the development of osteoarthritis Arthritis Rheum 50 2004 2531 2538
25. Y. Akasaki, S. Matsuda, K. Nakayama, S. Fukagawa, H. Miura, and Y. Iwamoto Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation Osteoarthritis Cartilage 17 2009 235 243
26. A.R. Shikhman, D. Amiel, D. D'Lima, S.B. Hwang, C. Hu, and A. Xu Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis Ann Rheum Dis 64 2005 89 94
27. H.J. Mankin, H. Dorfman, L. Lippiello, and A. Zarins Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data J Bone Joint Surg Am 53 1971 523 537
28. Heinecke LF, Grzanna MW, Au AY, Mochal CA, Rashmir-Raven A, Frondoza CG. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthritis Cartilage.18:220-7
29. R. Largo, M.A. Alvarez-Soria, I. Diez-Ortego, E. Calvo, O. Sanchez-Pernaute, and J. Egido Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes Osteoarthritis Cartilage 11 2003 290 298
30. L.C. Tetlow, D.J. Adlam, and D.E. Woolley Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes Arthritis Rheum 44 2001 585 594
31. J.P. Pelletier, P.J. Roughley, J.A. DiBattista, R. McCollum, and J. Martel-Pelletier Are cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum 20 1991 12 25
32. P.G. Mitchell, H.A. Magna, L.M. Reeves, L.L. Lopresti-Morrow, S.A. Yocum, and P.J. Rosner Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage J Clin Invest 97 1996 761 768
33. J.F. Woessner Jr., and Z. Gunja-Smith Role of metalloproteinases in human osteoarthritis J Rheumatol Suppl 27 1991 99 101
34. K. Brew, D. Dinakarpandian, and H. Nagase Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
35. F.X. Gomis-Ruth, K. Maskos, M. Betz, A. Bergner, R. Huber, and K. Suzuki Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 Nature 389 1997 77 81
36. N. Badlani, A. Inoue, R. Healey, R. Coutts, and D. Amiel The protective effect of OP-1 on articular cartilage in the development of osteoarthritis Osteoarthritis Cartilage 16 2008 600 606
37. L.D. Wu, H.C. Yu, Y. Xiong, and J. Feng Effect of dehydroepiandrosterone on cartilage and synovium of knee joints with osteoarthritis in rabbits Rheumatol Int 27 2006 79 85
38. J.P. Bao, W.P. Chen, J. Feng, J. Zhao, Z.L. Shi, and K. Huang Variation patterns of two degradation enzyme systems in articular cartilage in different stages of osteoarthritis: regulation by dehydroepiandrosterone Clin Chim Acta 408 2009 1 7